Key Takeaways
- • Carlyle Group generated $5.7 billion in realised proceeds from its Global Private Equity business in Q3 2026, according to DealStreetAsia.
- • The $720 million sale of a 27% stake in Japanese scientific instruments maker Rigaku to US-based Onto Innovation accounted for about 13% of the quarter's Global Private Equity realisations.
- • Carlyle's Global Private Equity business generated $23.6 billion in realised proceeds over the 12 months to September 2026.
- • Firm-wide realised carry fund proceeds totalled $8.8 billion in Q3, and carry fund proceeds reached $39.6 billion over the trailing 12 months, up 23%.
- • Carlyle ended September with $479 billion in assets under management, up 1% year on year, and $94 billion in available capital, up 5%.
Summary
Carlyle Group generated $5.7 billion in realised proceeds from its Global Private Equity business in the third quarter of 2026, with the $720 million sale of a stake in Japanese scientific equipment maker Rigaku among the largest exits of the period, according to DealStreetAsia's report on the firm's quarterly results.
The Rigaku transaction involved the sale of a 27% stake to US-based Onto Innovation. The deal was completed on August 10, with Onto acquiring 61.1 million existing shares from a Carlyle-affiliated vehicle. The disposal accounted for about 13% of Carlyle's Global Private Equity realisations in the quarter. Carlyle acquired an approximately 80% stake in Rigaku in 2021 through its fourth Japan buyout fund, Carlyle Japan Partners IV, partnering with the company's then management, who retained a roughly 20% holding. The company later went public in a 2024 IPO that raised 129 billion yen (about $863 million). Tokyo-based Rigaku makes analytical and metrology instruments, primarily using X-ray technology, for applications spanning semiconductor manufacturing, pharmaceuticals and advanced materials.
Other notable exits included Camino Natural Resources Holdings, an energy platform investment; Tescan Group, held in Carlyle's European technology funds; and VaroPreem, part of its international energy funds. Carlyle's Global Private Equity business generated $23.6 billion in realised proceeds over the 12 months to September 2026.
Across the firm, realised proceeds from carry funds totalled $8.8 billion in the third quarter, including $1.5 billion from global credit and $1.6 billion from Carlyle AlpInvest. Over the 12 months to September 30, carry fund proceeds reached $39.6 billion, up 23% from the preceding 12-month period.
Carlyle had $479 billion in assets under management at the end of September, up 1% year on year. Fee-earning assets under management stood at $330 billion, down 1%, while available capital rose 5% to $94 billion.
The Rigaku transaction involved the sale of a 27% stake to US-based Onto Innovation. The deal was completed on August 10, with Onto acquiring 61.1 million existing shares from a Carlyle-affiliated vehicle. The disposal accounted for about 13% of Carlyle's Global Private Equity realisations in the quarter. Carlyle acquired an approximately 80% stake in Rigaku in 2021 through its fourth Japan buyout fund, Carlyle Japan Partners IV, partnering with the company's then management, who retained a roughly 20% holding. The company later went public in a 2024 IPO that raised 129 billion yen (about $863 million). Tokyo-based Rigaku makes analytical and metrology instruments, primarily using X-ray technology, for applications spanning semiconductor manufacturing, pharmaceuticals and advanced materials.
Other notable exits included Camino Natural Resources Holdings, an energy platform investment; Tescan Group, held in Carlyle's European technology funds; and VaroPreem, part of its international energy funds. Carlyle's Global Private Equity business generated $23.6 billion in realised proceeds over the 12 months to September 2026.
Across the firm, realised proceeds from carry funds totalled $8.8 billion in the third quarter, including $1.5 billion from global credit and $1.6 billion from Carlyle AlpInvest. Over the 12 months to September 30, carry fund proceeds reached $39.6 billion, up 23% from the preceding 12-month period.
Carlyle had $479 billion in assets under management at the end of September, up 1% year on year. Fee-earning assets under management stood at $330 billion, down 1%, while available capital rose 5% to $94 billion.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.